Generics M&A to Focus On Emerging Markets

More News:

• 05/21/2013 Syrian Pharma Production Nearly Halted by WarFrom AFP

  A shortage of foreign currency has brought production to a near halt in Syria

• 05/21/2013 Camfil APC Opens Manufacturing Plant in the UKFrom Camfil

  Camfil announced the grand opening of its new 40,000-sq.-ft. facility

• 05/21/2013 Actavis Acquiring Warner Chilcott for $8.5BFrom AP

  Actavis to buy Warner Chilcott in an all-stock transaction

• 05/17/2013 Northwest Analytics Launches Next Generation Enterprise Manufacturing Intelligence SolutionFrom Northwest Analytics

  NWA Focus EMI Delivers Real Time Process Intelligence and Unique Accelerating Modules - a Shared Knowledge Base and Manufacturing-Centric Collaboration

• 05/16/2013 Innovative Clinical Development Partnership Announced By Quintiles and Merck SeronoFrom MarketWatch.com

  Agreement creates unique strategic collaboration for development and clinical trial execution

• 05/16/2013 $15 Billion Myland Offer Rejected By ActavisFrom Bloomberg.com

  Actavis has rejected drugmaker Mylan Inc's cash-and-stock offer for $15 billion. They have decided to continue talks to take over Warner Chilcott Plc instead, sources have said.

• 05/15/2013 Rapid Micro Biosystems Offers Workshops at New European Headquarters in MunichFrom Rapid Micro Biosystems

  Company hosts hands-on demonstrations of its Growth Direct System

• 05/13/2013 Amgen, Zhejiang Beta Pharma Form Joint VentureFrom FOX Business

  Amgen will form a joint venture with Chinese pharma firm to bring its colon cancer drug Vectibix to the Chinese market

• 05/13/2013 Academic Tech Transfer Collaboration Required for Pharma R&D ModelFrom IT News Online

  Pharma R&D Model Needs Academic Tech Transfer Collaboration for the Future of Drug Innovation Says New Report

• 05/09/2013 CEM Wins Solid-Phase Peptide Synthesis Patent DisputeFrom CEM

  CEM's European Patent covering microwave assisted solid phase peptide synthesis has been upheld in an oral proceeding

• All news »